相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
68Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma
Emre Demirci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
Christian M. Zechmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Limited evidence for the use of imaging to detect prostate cancer: A systematic review
L. Blomqvist et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Synthesis, Radiolabelling and In Vitro Characterization of the Gallium-68-, Yttrium-90- and Lutetium-177-Labelled PSMA Ligand, CHX-A-DTPA-DUPA-Pep
Benjamin Baur et al.
PHARMACEUTICALS (2014)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
PSMA as a target for radiolabelled small molecules
Matthias Eder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial
M. Bachner et al.
ANNALS OF ONCOLOGY (2012)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
Steve Y. Cho et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
Ying Chen et al.
CLINICAL CANCER RESEARCH (2011)
One Step Radiosynthesis of 6-[18F]Fluoronicotinic Acid 2,3,5,6-Tetrafluorophenyl Ester ([18F]F-Py-TFP): A New Prosthetic Group for Efficient Labeling of Biomolecules with Fluorine-18
Dag E. Olberg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
Sangeeta Ray Banerjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
K. P. Maresca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry-Standardization of Nomenclature
Wesley E. Bolch et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC:: A new imaging probe for prostate cancer
Ronnie C. Mease et al.
CLINICAL CANCER RESEARCH (2008)
Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?
C. Greco et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2008)
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy:: Results confirmed by open pelvic-retroperitoneal lymphadenectomy
Vincenzo Scattoni et al.
EUROPEAN UROLOGY (2007)
Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique
P. Mhawech-Fauceglia et al.
HISTOPATHOLOGY (2007)
Imaging prostate cancer: A multidisciplinary perspective
Hedvig Hricak et al.
RADIOLOGY (2007)
Positron emission tomography and molecular imaging of the prostate: an update
N Lawrentschuk et al.
BJU INTERNATIONAL (2006)
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer
IJ de Jong et al.
EUROPEAN UROLOGY (2003)
Value of [11C]choline-positron emission tomography for re-staging prostate cancer:: A comparison with [18F]fluorodeoxyglucose-positron emission tomography
M Picchio et al.
JOURNAL OF UROLOGY (2003)
Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis
A Turlakow et al.
ARCHIVES OF INTERNAL MEDICINE (2001)